Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis☆☆☆

Peter Howarth, Martin Stern, Larry D. Roi, Robert F. Reynolds, Jean Bousquet

Journal of Allergy and Clinical Immunology · 1999 · 164 citations · 14 references

DOIFull text

Open access

Concepts

References

14